Kaposi Sarcoma Market Anticipated to Grow at a CAGR of 4.12% During Forecast Period 2020-2025

January 6, 2021
Blessy

Kaposi Sarcoma Market size is valued at $122.4m by 2019, and is anticipated to grow at a CAGR of 4.12% during the forecast period 2020-2025. The Kaposi Sarcoma Market growth rate is attributed to the rising incidence of cancer. Kaposi sarcoma (KS) is a cancer that develops from the cells that line lymph or blood vessels, abnormal cells of KS form purple, red, or brown blotches or tumors on the skin called as lesions. As, Kaposi sarcoma is easily caught by a body with weaker immune system, the chances of Kaposi sarcoma occurrence increase, which in turn fuel the market’s growth. From improvement’s made on reduction in drug resistance, lowering failure rate, few side effects, and the decreasing case-fatality ratios to the growing emphasis on combination therapy is anticipated to propel the Kaposi Sarcoma Market during the forecast period 2020-2025.

Key Takeaways

  • North America dominated the Kaposi Sarcoma Market with a share of 38% in the year 2019.
  • The factors such as rising research and development activities in this field and the technological advancements, increasing mergers and acquisitions and strategic collaboration are amongst the major factor projected to impel growth of Kaposi Sarcoma Market.
  • Increase in demand for food & beverage products with an extended shelf life, marginal nutritional changes in products such as milk, and reduction in logistics and storage cost are the key factors owing to the growth in the segment during forecast period 2020-2025.

Request for Sample of the Report @ https://www.industryarc.com/pdfdownload.php?id=17349

Report Price: $ 4500 (Single User License)  

Drivers – Kaposi Sarcoma Market

  • Rising demand of patients undergoing organ transplant procedures  

Kaposi Sarcoma Industry Outlook

Product launches, mergers and acquisitions, joint ventures and geographical expansions are key strategies adopted by players in the Kaposi Sarcoma Market. In 2019, Kaposi Sarcoma Market share is fragmented by the top ten players present in the market. Kaposi Sarcoma Market top 10 companies are Eli Lilly and Company, Pfizer, Bristol-Myers Squibb, Johnson & Johnson, GlaxoSmithKline, Merck, Quest Diagnostics, Navidea Biopharmaceuticals Inc., MBio Diagnostics, Cleveland Clinic and others.

About IndustryARC : IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to sales@industryarc.com to discuss more about our consulting services.

Article Categories:
BUSINESS

Leave a Comment